These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 23759297

  • 21. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 22. [Fibrillary glomerulonephritis--a rare cause of nephrotic syndrome].
    Strebl P, Tichý M, Krejcí K, Al Jabry S, Horcicka V, Husek K, Vernerová Z, Zadrazil J.
    Vnitr Lek; 2004 Aug; 50(8):624-7. PubMed ID: 15521207
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis.
    Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A, Sumida K, Mise K, Yamanouchi M, Ueno T, Sekine A, Hayami N, Suwabe T, Hoshino J, Takaichi K, Ohashi K, Fujii T, Wake A, Taniguchi S.
    Hum Pathol; 2016 Apr; 50():187-94. PubMed ID: 26997455
    [Abstract] [Full Text] [Related]

  • 24. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 25. [Fibrillary glomerulonephritis].
    Rysavá R, Merta M, Zabka J, Reiterová J, Ríhová Z, Tesar V.
    Sb Lek; 2003 Feb; 104(1):85-93. PubMed ID: 14577139
    [Abstract] [Full Text] [Related]

  • 26. Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis.
    Sharma P, Kuperman M, Racusen L, Geetha D.
    Am J Kidney Dis; 2012 Jul; 60(1):157-9. PubMed ID: 22398109
    [Abstract] [Full Text] [Related]

  • 27. Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis: A case series.
    Marinaki S, Tsiakas S, Liapis G, Skalioti C, Kapsia E, Lionaki S, Boletis J.
    Medicine (Baltimore); 2021 May 21; 100(20):e26022. PubMed ID: 34011106
    [Abstract] [Full Text] [Related]

  • 28. Impact of recurrent glomerulonephritis on renal graft survival.
    Toledo K, Pérez-Sáez MJ, Navarro MD, Ortega R, Redondo MD, Agüera ML, Rodríguez-Benot A, Aljama P.
    Transplant Proc; 2011 May 21; 43(6):2182-6. PubMed ID: 21839228
    [Abstract] [Full Text] [Related]

  • 29. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec 21; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 30. Outcome of fibrillary glomerulonephritis.
    Kalbermatter SA, Marone C, Casartelli D, Hausberg M, Banfi G, Mihatsch M, Dickenmann M.
    Swiss Med Wkly; 2012 Dec 21; 142():w13578. PubMed ID: 22553112
    [Abstract] [Full Text] [Related]

  • 31. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep 21; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Glomerular deposition disease, regarding a case of fibrillary glomerulonephritis].
    Cantillo Jde J, López Rdel P, Andrade RE.
    Biomedica; 2009 Dec 21; 29(4):539-46. PubMed ID: 20440452
    [Abstract] [Full Text] [Related]

  • 35. Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.
    Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, Bridoux F, Vanhille P, Makdassi R, Augusto JF, Rouvier P, Karras A, Jouanneau C, Verpont MC, Callard P, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Saadoun D, Ronco P, Brochériou I, Cacoub P, Plaisier E, CryoVas study group.
    J Am Soc Nephrol; 2016 Apr 21; 27(4):1213-24. PubMed ID: 26260165
    [Abstract] [Full Text] [Related]

  • 36. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.
    Sprangers B, Bomback AS, Cohen SD, Radhakrishnan J, Valeri A, Markowitz GS, D'Agati V, Appel GB.
    Am J Nephrol; 2012 Apr 21; 36(1):78-89. PubMed ID: 22739228
    [Abstract] [Full Text] [Related]

  • 37. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness.
    Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F.
    Am J Kidney Dis; 2002 Sep 21; 40(3):E9. PubMed ID: 12200826
    [Abstract] [Full Text] [Related]

  • 38. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.
    Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Nachman PH.
    Clin J Am Soc Nephrol; 2014 May 21; 9(5):905-13. PubMed ID: 24578329
    [Abstract] [Full Text] [Related]

  • 39. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis.
    Grove P, Neale PH, Peck M, Schiller B, Haas M.
    Mod Pathol; 1998 Jan 21; 11(1):103-9. PubMed ID: 9556416
    [Abstract] [Full Text] [Related]

  • 40. Immunotactoid glomerulopathy: clinicopathologic and proteomic study.
    Nasr SH, Fidler ME, Cornell LD, Leung N, Cosio FG, Sheikh SS, Amir AA, Vrana JA, Theis JD, Dogan A, Sethi S.
    Nephrol Dial Transplant; 2012 Nov 21; 27(11):4137-46. PubMed ID: 22872726
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.